Ceftolozane–tazobactam for the treatment of osteomyelitis caused by multidrug-resistant pathogens: a case series
Ceftolozane–tazobactam (CT) is a recently approved novel cephalosporin and β-lactamase inhibitor combination agent with in vitro activity against various Gram-positive and Gram-negative pathogens, including several multidrug-resistant (MDR) Gram-negative organisms. CT is currently approved by the US...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
SAGE Publishing
2019
|
| Subjects: | |
| Online Access: | https://doaj.org/article/982b73dfcb534ff0a6e19da8767df082 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|